Effect of supplementation in treatment of Hemodialysis patients
Phase 3
- Conditions
- Hemodialysis.Chronic kidney disease
- Registration Number
- IRCT201410245623N28
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Patients aged 18-80 years with Hemodialysis status
Exclusion Criteria
Pregnant
Taking antioxidant supplements or immunosuppressive medications within 3 months prior to enrollment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SGA score. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation.;Malondialdehyde. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Spectrophotometry.
- Secondary Outcome Measures
Name Time Method